Adult antiandrogen results do not make oral spironolactone routine care for teens with inflammatory acne. They support staying with proven topicals first, then adding a teen-appropriate hormonal option for adolescent girls when hormones drive breakouts.
An antiandrogen is a treatment that blocks male-type hormone signals that increase oil production. Inflammatory acne means red, tender pimples and deeper lumps. A 2026 narrative review in Clinical, Cosmetic and Investigational Dermatology compared systemic and local spironolactone as a non-antibiotic antiandrogen option for adult female acne.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- How do antiandrogens calm acne?
- What did the adult trials show?
- Which hormonal option is labeled for teens?
- Why does oral spironolactone stay restricted in teens?
How do antiandrogens calm acne?
Spironolactone blocks dihydrotestosterone from binding androgen receptors in oil-gland cells. That action slows androgen-driven growth of those cells. It also lowers oil output in a dose-dependent way, according to the American Journal of Clinical Dermatology. Less oil means fewer clogged pores and less fuel for inflammation.
That matters for jawline papules, tender chin nodules, and flares around periods. It does not replace killing acne bacteria or clearing plugs directly. Topical clascoterone works closer to the skin by blocking the androgen receptor in the skin. Oral spironolactone works through the whole body. That difference shapes safety, monitoring, and teen use.
What did the adult trials show?
The UK SAINT trial enrolled 410 adult women. The University of Southampton reports improvement in self-reported acne and quality of life with spironolactone versus placebo, with a gap at 12 weeks and larger gains by 24 weeks trial summary. The FASCE trial enrolled 133 adult women with moderate acne.
The Inserm HAL record of that multicentre double-blind trial found spironolactone 150 mg per day superior to doxycycline 100 mg per day, with treatment-success odds ratio 2.87 at 6 months plus better acne, severity, and quality-of-life scores FASCE trial record. These were adult female populations, not teen populations. Results support antiandrogen treatment for adult female acne. They do not set a teen dose or timeline.
Which hormonal option is labeled for teens?
Clascoterone 1% cream is the only antiandrogen formulation directly labeled for teens. Drugs.com records its FDA approval on Aug.
26, 2020 for acne vulgaris in patients 12 years and older FDA approval history. Current AAD guidance conditionally recommends spironolactone, combined oral contraceptives, and topical clascoterone, while strongly recommending benzoyl peroxide, retinoids, topical antibiotics, and isotretinoin for severe disease, according to the Guideline Central summary AAD guideline summary. For an adolescent girl with oily skin plus period-linked flares, practical paths include:.
- keep a topical retinoid plus benzoyl peroxide as the base routine
- ask about topical clascoterone where a local hormone-blocking effect is wanted
- discuss combined oral contraceptives when contraception, cycle control, or broader hormonal signs are also relevant
- save oral spironolactone for persistent, refractory, or high-androgen cases after pediatric-dermatology review
Why does oral spironolactone stay restricted in teens?
Oral spironolactone is potassium-sparing and off-label for acne. A 2025 Clinician review notes possible high potassium, irregular periods, feminizing effects in a fetus, and fetal harm. That risk profile generally limits use to females using reliable birth control with medical monitoring.
It also needs potassium checks and review of other drugs and health conditions. Teens need a clinician to weigh growth, development, pregnancy risk, and follow-up. Dermatology expert guidance reported by MDedge Dermatology points teens toward continued retinoid, benzoyl peroxide, and topical antibiotic care, with combined oral contraceptives or topical clascoterone for hormonal disease in adolescent girls. Oral spironolactone remains a later choice for selected persistent or hyperandrogenic cases after specialty evaluation.
You Might Also Like
- Topical Hormonal Acne Treatments in a 2026 Review: What the Findings Mean for Teens With Inflammatory Acne
- Limited Topical Spironolactone Evidence in the 2026 Review: What the Findings Mean for Teens With Inflammatory Acne
- Topical Clascoterone Evidence Revisited in 2026: What the Findings Mean for Teens With Inflammatory Acne